5 New Stock Picks of Billionaire Ken Fisher

Page 1 of 5

In this article, we discuss the 5 new stock picks of billionaire Ken Fisher. If you want to read our detailed analysis of these stocks, go directly to the 10 New Stock Picks of Billionaire Ken Fisher.

5. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Number of Hedge Fund Holders: 16     

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a biotech firm that develops therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases. Regulatory filings show that Fisher Asset Management owned 201,801 shares in the company at the end of the third quarter of 2021 worth over $1 million, representing a very small portion of the portfolio. 

Piper Sandler analyst Joseph Catanzaro recently kept an Overweight rating on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stock and raised the price target to $7 from $6.5, forecasting organic growth for the firm on the back of new patient enrollments. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Armistice Capital is a leading shareholder in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) with 10 million shares worth more than $57 million. 

Page 1 of 5